NetworkNewsBreaks – Golden Triangle Ventures Inc
Post# of 222
(Total Views: 244)
Posted On: 07/07/2021 3:23:17 PM
NetworkNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Founding Member Writes Shareholder Letter
Golden Triangle Ventures (OTC: GTVH) and founding member Nathan Puente, CEO of Sonder Fulfillment LLC, have released a mid-year letter to shareholders. The letter provides an update on current activities and also outlines the corporate strategy of Sonder, a company that GTVH, a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries, has signed a letter of intent to acquire. In the letter, Puente notes that the goal of Sonder Fulfillment is to educate people around the world about the hemp plant and its potential as a natural substitute to harsh prescription medication. Puente observed that providing natural products that help people live fuller, healthier lives is the company’s mission and what gets Sonder employees out of bed in the morning. Sonder, which is made up of pharmacologists, chemists and formulary scientists, has a history of being actively engaged in understanding the human endocannabinoid system (“ECS”) and its research has focused on arthritis, Alzheimer’s, Crohn’s disease, psoriasis, osteoporosis, PTSD and various cancers, as well cosmetic, healthcare and mental health issues. The company has even produced products for acne, hair loss, skin care, GI/gut issues and nootropic remedies. “Our marriage with Golden Triangle Ventures has vastly opened our team’s research bandwidth and production capabilities used to deliver the best cannabinoid driven products to your doorstep,” said Sonder Fulfillment CEO Nathan Puente. “We take great pride in our research, processing, production and white label ventures within our organization, and we set the highest standards on all of our end products. In the months ahead, we intend to release additional products that I believe will address many well-known medical issues and we plan to expand on every aspect within our company. This business derives from years of planning to get to where we are today, and it is great witnessing it develop into the business we have always dreamed it becoming.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Golden Triangle Ventures (OTC: GTVH) and founding member Nathan Puente, CEO of Sonder Fulfillment LLC, have released a mid-year letter to shareholders. The letter provides an update on current activities and also outlines the corporate strategy of Sonder, a company that GTVH, a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries, has signed a letter of intent to acquire. In the letter, Puente notes that the goal of Sonder Fulfillment is to educate people around the world about the hemp plant and its potential as a natural substitute to harsh prescription medication. Puente observed that providing natural products that help people live fuller, healthier lives is the company’s mission and what gets Sonder employees out of bed in the morning. Sonder, which is made up of pharmacologists, chemists and formulary scientists, has a history of being actively engaged in understanding the human endocannabinoid system (“ECS”) and its research has focused on arthritis, Alzheimer’s, Crohn’s disease, psoriasis, osteoporosis, PTSD and various cancers, as well cosmetic, healthcare and mental health issues. The company has even produced products for acne, hair loss, skin care, GI/gut issues and nootropic remedies. “Our marriage with Golden Triangle Ventures has vastly opened our team’s research bandwidth and production capabilities used to deliver the best cannabinoid driven products to your doorstep,” said Sonder Fulfillment CEO Nathan Puente. “We take great pride in our research, processing, production and white label ventures within our organization, and we set the highest standards on all of our end products. In the months ahead, we intend to release additional products that I believe will address many well-known medical issues and we plan to expand on every aspect within our company. This business derives from years of planning to get to where we are today, and it is great witnessing it develop into the business we have always dreamed it becoming.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)